Iohexol Imax (Iohexol)

Iohexol contains a high density of iodine atoms, which absorb X‑ray photons more effectively than surrounding tissues. When injected, the iodine‑rich solution circulates through the bloodstream and tissues, creating areas of increased attenuation that appear brighter on X‑ray‑based images, thereby improving the contrast between structures.

The dose of Iohexol Imax is determined by the prescribing physician based on the specific imaging study, patient weight, renal function, and the required level of contrast. Healthcare professionals calculate the appropriate volume and concentration to achieve optimal image quality while minimizing risk.

The safety of Iohexol Imax in pregnancy and lactation has not been definitively established. It should be used only if the diagnostic benefit outweighs potential risks, and the decision should be made by the treating physician in consultation with obstetric or pediatric specialists.

To order Iohexol Imax, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Iohexol Imax is comparable to other non‑ionic, low‑osmolality iodinated contrast media in terms of image enhancement and safety profile. Compared with older high‑osmolality agents, Iohexol typically offers reduced incidence of discomfort and adverse reactions, while providing similar diagnostic efficacy for CT and angiographic studies.

Iohexol Imax should be stored at temperatures below 25 °C, in its original sealed container, protected from light and moisture. Do not freeze the product. Before use, inspect the vial for particulate matter or discoloration and handle with aseptic technique.

Iohexol Imax is supplied as a sterile solution for injection and is administered by a qualified healthcare professional via intra‑arterial, intravenous, or intrathecal routes, depending on the imaging procedure. The injection is typically performed using a power injector or manual bolus under imaging guidance.

The most serious risks include severe allergic reactions such as anaphylaxis, acute kidney injury especially in patients with pre‑existing renal impairment, and rare cardiovascular events like hypotension or cardiac arrest. Immediate medical attention is required if any of these serious reactions occur.

Iohexol Imax should be avoided in patients with a known hypersensitivity to iodinated contrast media, uncontrolled hyperthyroidism, severe renal insufficiency, or in those who have experienced a prior severe reaction to a similar agent. Clinicians must evaluate each patient’s medical history before administration.